Search

everythinglearnresearchcommunity

for

Search:↓

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

TAK-279 effectively reduces psoriasis symptoms and is safe.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Potassium channel modulators mostly increase the activity of rat whisker mechanoreceptors.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Lack of TrkC receptor delays hair follicle development.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

TRPV1 is involved in pain, various body functions, and diseases, but targeting it for treatment is challenging.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.